<DOC>
	<DOCNO>NCT00439504</DOCNO>
	<brief_summary>The purpose study determine significant cardiovascular interaction sublingual lobeline intravenous methamphetamine .</brief_summary>
	<brief_title>Ph1 Lobeline Interaction Study - 1</brief_title>
	<detailed_description />
	<mesh_term>Lobeline</mesh_term>
	<criteria>Be age 18 45 year age Be general good health history methamphetamine ( MA ) abuse ( dependence ) If female child bear potential , agree use birth control Be able understand provide write informed consent Have body mass index 18 30 Have report use ( MA ) past three month without experience adverse consequence plus life time MA amphetamine use history least four occasion use Have negative drug test ( barbiturate , benzodiazepine , amphetamine , opiate , cocaine , cannabinoids , ethanol ) screening time admission Please contact site detail</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>